Agents and actions. Supplements 1991-01-01

A new antiinflammatory agent (EGIS-5645) without gastrointestinal side-effect.

G Gigler, E Kiszelly, P Tömpe, G Kovács, K Gadó

Index: Agents Actions. Suppl. 32 , 39-43, (1991)

Full Text: HTML

Abstract

The compound EGIS-5645 is a potent antipyretic agent possessing analgesic and antiinflammatory properties. The drug is active in antiinflammatory models such as carrageenin oedema and adjuvant arthritis. EGIS-5645 shows practically no gastro-ulcerogenic effect. The molecule does not inhibit either prostaglandin biosynthesis or soybean lipoxygenase enzyme activity.

Related Compounds

  • Diaveridine

Related Articles:

[Polarographic determination of diaveridine in biological samples].

1990-01-01

[Acta Pharm. Hung. 60(1) , 23-9, (1990)]

Inhibitors of folic acid synthesis in the treatment of experimental Pneumocystis carinii pneumonia.

1988-01-01

[Antimicrob. Agents Chemother. 32(1) , 96-103, (1988)]

Demonstration of synergistic effects of sulfonamides and dihydrofolate reductase/thymidylate synthase inhibitors against Neospora caninum tachyzoites in cultured cells, and characterization of mutants resistant to pyrimethamine.

1996-01-01

[Am. J. Vet. Res. 57(1) , 68-72, (1996)]

Determination of residual diaveridine and sulfaquinoxaline in Hen's egg, chicken plasma and tissues by high-performance liquid chromatography.

1981-08-01

[Chem. Pharm. Bull. 29(8) , 2290-5, (1981)]

Mutagenicity of the coccidiostat diaveridine in the Salmonella/mammalian microsome assay.

1991-10-01

[Mutat. Res. 261(2) , 149-52, (1991)]

More Articles...